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Background: Health care professionals (HCPs) are able to make effective decisions regarding patient care through
the use of systematically developed clinical practice guidelines (CPGs). These recommendations are especially
important in a cancer health care context as patients are exposed to a multitude of interdisciplinary HCPs offering
high-quality care throughout diagnosis, treatment, survivorship and palliative care. Although a large number of
CPGs targeted towards cancer are widely disseminated, it is unknown whether implementation strategies targeting
the use of these guidelines are effective in effecting HCP behaviour and patient outcomes in the cancer care
context. The purpose of this systematic review will be to determine the effectiveness of different CPG dissemination
and implementation interventions on HCPs’ behaviour and patient outcomes in the cancer health care context.
Methods/design: Five electronic databases (CINAHL, the Cochrane Controlled Trials Register, MEDLINE via Ovid,
EMBASE via Ovid and PsycINFO via Ovid) will be searched to include all studies examining the dissemination
and/or implementation of CPGs in a cancer care setting targeting all HCPs. CPG implementation strategies will
be included if the CPGs were systematically developed (e.g. literature review/evidence-informed, expert panel,
evidence appraisal). The studies will be limited to randomized controlled trials, controlled clinical trials and
quasi-experimental (interrupted time series, controlled before-and-after designs) studies. Two independent
reviewers will assess articles for eligibility, data extraction and quality appraisal.
Discussion: The aim of this review is to inform cancer care health care professionals and policymakers about
evidence-based implementation strategies that will allow for effective use of CPGs.
Systematic review registration: PROSPERO CRD42015019331
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Clinical practice guidelines (CPGs)—‘systematically de-
veloped statements to assist practitioner and patient de-
cisions about appropriate health care for specific clinical
circumstances’ [1]—provide health care professionals
(HCPs) with synthesized, evidence-based guidance for
making decisions regarding the care of patients. The use
of CPGs has the potential to improve quality of health
care delivery and patient outcomes [2]. The development
of a CPG does not, however, guarantee its use in practice
without targeted dissemination and implementation in-
terventions [3], or purposeful strategies for achieving
practice adherence with a guideline recommendation.
Over the past few decades, a burgeoning interest in the
effectiveness of CPG dissemination and implementation
strategies has led to systematic reviews examining the
impact of such interventions on medical (e.g. [4]) and al-
lied HCPs (e.g. [5]), as well as to reviews of reviews (e.g.
[6]). However, a review examining the effectiveness of
CPG dissemination and implementation interventions
specifically targeting HCPs in the cancer care context
has yet to be conducted.
The cancer health care context is unique as a number of
medical and allied HCPs are involved in different stages of
the cancer care continuum (from patients’ diagnosis,
treatment, survivorship, to palliative care), and have to
function as a multidisciplinary team to provide optimal
care [7, 8]. Further, as advances in cancer treatment, and
thus the evidence base underpinning CPGs, continue to
evolve at a rapid pace, CPGs require routine and frequent
updating to ensure recommendations remain current and
valid [9, 10]. As a consequence, this presents unique chal-
lenges for adopters of recommendations, requiring for in-
stance, HCPs in this context to stay abreast of the most
recent best-practice recommendations and be nimble
enough to accommodate refinements or changes to their
practice routines. An understanding of the effectiveness of
CPG guideline and dissemination strategies specifically
within the cancer care context can inform the develop-
ment of such interventions in the future. Therefore, the
purpose of this systematic review will be to determine the
effectiveness of different CPG dissemination and imple-
mentation interventions on HCPs’ behaviour and patient
outcomes in the cancer health care context.
Methods/design
This systematic review is informed by reviews that syn-
thesized literature examining the effectiveness of guide-
line dissemination and implementation interventions on
medical [4] and allied HCPs [5] across all health care
contexts. To ensure methodological rigour, the results of
this review will be reported according to the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guideline [11]. This systematicreview protocol is registered in the PROSPERO database
(CRD42015019331).
Eligibility criteria
Studies will be selected according to the criteria outlined
below.
Study designs
Peer-reviewed and published experimental (randomized
controlled trials, controlled clinical trials) and quasi-
experimental (interrupted time series, controlled before-
and-after designs) studies will be included in the search.
We will exclude cross-sectional, cohort, qualitative only,
retrospective, and case studies, as well as any studies
without primary data (e.g. editorials, commentaries). Un-
published data, abstracts and conference proceedings
will also be excluded.
Participants
Studies examining the dissemination and/or implementa-
tion of CPGs among medically qualified (e.g. physicians,
nurses) and allied HCPs (e.g. dietetics, rehabilitation ther-
apy, pharmacy, psychology, radiography, social work) who
work within the cancer care context will be included.
Studies evaluating the introduction of CPGs targeting pa-
tients, the general public, or hospital administrators or
policymakers (who are not HCPs themselves), without tar-
geting HCPs, will be excluded.
Interventions
Guidelines, clinical guidelines, practice guidelines, guid-
ance, advice, recommendations, expert opinion and con-
sensus statements will be considered under the ‘CPG’
umbrella if the study reports that they were systematic-
ally developed (e.g. literature review/evidence-informed,
expert panel, evidence appraisal). All CPG dissemination
and implementation interventions/strategies will be in-
cluded and classified according to the Mazza taxonomy
[12]. The Mazza taxonomy builds upon the Cochrane Ef-
fective Practice and Organization of Care (EPOC) group’s
data collection checklist [13], and categorizes 49 types of
CPG dissemination and implementation strategies targeting
HCPs into professional, organizational, financial, and regu-
latory approaches. Mazza’s [12] taxonomy has been peer-
reviewed and pilot-tested [14], and has been used to classify
CPG implementation interventions in other systematic re-
views (e.g. [15]). Interventions that are not designed to en-
hance the dissemination and/or implementation of a CPG
will be excluded.
Comparators
Within each study, separate comparisons will be made for
the following: (1) single intervention vs. no-intervention
control; (2) single intervention vs. control that receives
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intervention control; and (4) multifaceted intervention vs.
control that receives some intervention.Outcomes
The primary outcome will be an objective measure of
HCP behaviour in line with the CPG recommendation
(e.g. diagnosis, test ordering, referrals, procedures, pre-
scribing, general management of cancer/chronic disease,
patient education/advice). Secondary outcomes will in-
clude patient outcomes (e.g., quality of life, less recur-
rence of cancer) resulting from dissemination and use of
the CPG by HCPs.Timing
There will be no restrictions by length of follow-up of
outcomes; however, maintenance of outcomes will be
noted in final manuscript.Setting
To be included in the review, the dissemination and/or
implementation strategies must have been implemented
in any cancer setting or context related to cancer care.Search strategy
We will search MEDLINE (OVID interface), EMBASE
(OVID interface), PsycINFO (OVID interface), CINAHL,
and the Cochrane Controlled Trials Register. The litera-
ture search will be limited to the English language (given
resources are not available for translation) and human
subjects. To exclusively capture studies that were not
previously included in last systematic review of the ef-
fectiveness of dissemination and implementation strat-
egies for CPGs among medical HCPs [4], the literature
search will be limited to articles published since 1998.
A search strategy will be built based on the EPOC
Group strategy [16] and previous systematic reviews
examining guideline dissemination and implementation
among medical and allied HCPs ([4] and [5], respect-
ively). The search strategy will combine terms relevant
to guideline implementation strategies, medical and al-
lied HCPs, outcomes, trial design, and cancer care. The
MEDLINE strategy will be developed and then be peer-
reviewed by a health sciences librarian with expertise in
systematic review searching who is not on our study
team. A draft MEDLINE search strategy is included in
Additional file 1. Once the MEDLINE strategy is final-
ized, it will be adapted for the syntax and subject head-
ings of the other databases. To ensure literature
saturation, the reference lists of relevant reviews identi-
fied through the search will be hand-searched.Data extraction
Literature search results will be uploaded to EndNote X7
reference management software. References will be de-
duplicated by comparing citation details, such as author
names, year of publication, article title, and journal. Two
reviewers will independently screen titles and abstracts of
the de-duplicated bibliographic records. Full texts of re-
cords passing the title and abstract screening level will be
retrieved and examined independently by the two re-
viewers according to the eligibility criteria above. Dis-
agreements at both screening levels will be resolved
through discussion. A PRISMA flow chart will outline the
study selection process and reasons for exclusions.
A data extraction form will be created based on the
data collection checklist used for Grimshaw and col-
leagues’ [4] review; however, modifications will be made
to account for the inclusion of allied HCP and the can-
cer care context. The form will be pilot tested by two re-
viewers (JRT, RC) prior to full data extraction. Each
reviewer will extract data from the same five full-text ar-
ticles to determine the feasibility and acceptability of the
created data form, and required modifications to the
form will be made. The following data will be extracted
from each full-text article: (1) study design; (2) quality
criteria (based on the Methodological Criteria in the
Cochrane EPOC Data Collection Checklist, more infor-
mation below; [13]); (3) characteristics of participating
providers; (4) characteristics of participating patients; (5)
setting; (6) intervention characteristics (including char-
acteristics of the CPGs, type of intervention, and com-
parator group); (7) outcomes (including both HCP
outcomes/process measures and patient outcomes, as
well as post-intervention follow-up); and (8) results.
These variables will be extracted for all studies by one
reviewer (RC), and then verified by a second reviewer
(JRT) to reduce reviewer errors and bias. Disagreements
will be resolved by discussion. Multiple publications of
the same study will be identified and noted in the
PRISMA flow chart.
Quality assessment
The Cochrane Collaboration tool for assessing the risk
of bias [17] will be used to assess the risk of bias for
RCTs. Information about the article’s sequence gener-
ation, allocation concealment, blinding, incomplete out-
come data (e.g. dropouts and withdrawals) and selective
outcome reporting will be extracted, and a judgment will
be made as whether the study is at ‘high risk’ or ‘low
risk’ of bias. If there is insufficient detail reported, the
risk of bias will be noted as ‘unclear’.
The Cochrane Risk of Bias Assessment Tool for Non-
Randomized Studies of Interventions [18] will be used to
assess the risk of bias for studies using quasi-
experimental designs. Information about confounding,
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departures from intended interventions, missing data,
measurement of outcomes, and selection of the reported
result will be extracted, and a judgment will be made as
whether the study is at ‘critical’, ‘serious’, ‘moderate’, or
‘low’ risk of bias for each category. If there is insufficient
detail reported for a given category, the risk of bias will
be noted as ‘no information’ on which to base a judgment
of risk of bias.
Risk of bias will be determined for all studies by one
reviewer (RC), and then verified by a second reviewer
(JRT). Disagreements will be resolved by discussion.
Data synthesis
Due to the anticipated heterogeneity in study outcomes
and comparator (c.f. [4]) across a small number of exist-
ing trials, a meta-analysis will not be conducted [19]. In-
stead, a systematic description and narrative synthesis
will be provided. Tables will be used to qualitatively de-
scribe the studies pertaining to study design (experimen-
tal or quasi-experimental), population (HCP and patient
characteristics), intervention characteristics, comparator,
and outcomes (HCPs/process outcomes, and/or patient
outcomes). In-text results will first be presented accord-
ing to type of implementation strategy (e.g. professional
vs. financial interventions), then by single vs. multifa-
ceted strategies (with results stratified by ‘no interven-
tion’ and ‘some intervention’ comparators), then by
process vs. patient outcomes. If the necessary data are
available, subgroup analyses will be done for medically
qualified HCPs and allied HCPs, separately.1 All studies
will be reported, regardless of level of risk of bias; how-
ever, we will note where high risk of bias may influence
the interpretation of the review findings.
Discussion
A comprehensive review of the effectiveness of CPG dis-
semination and implementation strategies in the cancer
care context does not yet exist in the literature. Previous
reviews examining the effectiveness of CPG implementa-
tion interventions have either examined medical HCPs
[4] or allied HCPs [5] across all health care contexts.
Given the numerous CPGs that are routinely produced
and updated to inform decisions in the care of people
with cancer and that patients with cancer undergo sev-
eral transitions in care between a multidisciplinary team
of HCPs [7, 8], this review will provide insight into the
effectiveness of CPG implementation strategies specific
to this context. The findings of this systematic review
will have the potential to inform researchers and practi-
tioners who are interested in developing interventions
that enhance CPG dissemination and implementation
among both medical and allied HCPs’ in the cancer
care context.Endnotes
1In order to be included in subgroup analyses, studies
will have to report outcomes separately (medical vs. al-
lied HCPs). If the study sample is >50 %, medical HCPs
and the results are not presented separately for the two
types of HCPs, the sample will be grouped as medical
HCPs (and vice versa).
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Additional file 1: Medline search strategy. Search terms and order for
searching Medline database. (pdf 147 KB)
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